My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 94

    1.

    Relative persistence of AAV serotype 1 vector genomes in dystrophic muscle.

    Pacak CA, Conlon T, Mah CS, Byrne BJ.

    Genet Vaccines Ther. 2008 Oct 15;6:14.PMID: 18854054 [PubMed - in process]Related articlesFree article

    2.

    Long-term skeletal muscle protection after gene transfer in a mouse model of LGMD-2D.

    Pacak CA, Walter GA, Gaidosh G, Bryant N, Lewis MA, Germain S, Mah CS, Campbell KP, Byrne BJ.

    Mol Ther. 2007 Oct;15(10):1775-81. Epub 2007 Jul 24.PMID: 17653106 [PubMed - indexed for MEDLINE]Related articles

    3.

    Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice.

    Xu R, DeVries S, Camboni M, Martin PT.

    Am J Pathol. 2009 Jul;175(1):235-47. Epub 2009 Jun 4.PMID: 19498002 [PubMed - indexed for MEDLINE]Related articles

    4.

    Delivery of alpha- and beta-sarcoglycan by recombinant adeno-associated virus: efficient rescue of muscle, but differential toxicity.

    Dressman D, Araishi K, Imamura M, Sasaoka T, Liu LA, Engvall E, Hoffman EP.

    Hum Gene Ther. 2002 Sep 1;13(13):1631-46.PMID: 12228018 [PubMed - indexed for MEDLINE]Related articles

    5.

    Recombinant adeno-associated virus type 8-mediated extensive therapeutic gene delivery into skeletal muscle of alpha-sarcoglycan-deficient mice.

    Nishiyama A, Ampong BN, Ohshima S, Shin JH, Nakai H, Imamura M, Miyagoe-Suzuki Y, Okada T, Takeda S.

    Hum Gene Ther. 2008 Jul;19(7):719-30.PMID: 18578595 [PubMed - indexed for MEDLINE]Related articles

    6.

    Muscles of mice deficient in alpha-sarcoglycan maintain large masses and near control force values throughout the life span.

    Consolino CM, Duclos F, Lee J, Williamson RA, Campbell KP, Brooks SV.

    Physiol Genomics. 2005 Jul 14;22(2):244-56. Epub 2005 May 10.PMID: 15886330 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D.

    Rodino-Klapac LR, Lee JS, Mulligan RC, Clark KR, Mendell JR.

    Neurology. 2008 Jul 22;71(4):240-7. Epub 2008 Jun 4.PMID: 18525034 [PubMed - indexed for MEDLINE]Related articles

    8.

    Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo.

    Pacak CA, Mah CS, Thattaliyath BD, Conlon TJ, Lewis MA, Cloutier DE, Zolotukhin I, Tarantal AF, Byrne BJ.

    Circ Res. 2006 Aug 18;99(4):e3-9. Epub 2006 Jul 27.PMID: 16873720 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Phenotypic correction of alpha-sarcoglycan deficiency by intra-arterial injection of a muscle-specific serotype 1 rAAV vector.

    Fougerousse F, Bartoli M, Poupiot J, Arandel L, Durand M, Guerchet N, Gicquel E, Danos O, Richard I.

    Mol Ther. 2007 Jan;15(1):53-61.PMID: 17164775 [PubMed - indexed for MEDLINE]Related articles

    10.

    Limb-girdle muscular dystrophy type 2D gene therapy restores alpha-sarcoglycan and associated proteins.

    Mendell JR, Rodino-Klapac LR, Rosales-Quintero X, Kota J, Coley BD, Galloway G, Craenen JM, Lewis S, Malik V, Shilling C, Byrne BJ, Conlon T, Campbell KJ, Bremer WG, Viollet L, Walker CM, Sahenk Z, Clark KR.

    Ann Neurol. 2009 Sep;66(3):290-7.PMID: 19798725 [PubMed - indexed for MEDLINE]Related articles

    11.
    12.

    Alternate serotype adenovector provides long-term therapeutic gene expression in the eye.

    Hamilton MM, Byrnes GA, Gall JG, Brough DE, King CR, Wei LL.

    Mol Vis. 2008;14:2535-46. Epub 2008 Dec 30.PMID: 19122827 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Transduction efficiency and immune response associated with the administration of AAV8 vector into dog skeletal muscle.

    Ohshima S, Shin JH, Yuasa K, Nishiyama A, Kira J, Okada T, Takeda S.

    Mol Ther. 2009 Jan;17(1):73-80. Epub 2008 Oct 21.PMID: 18941441 [PubMed - indexed for MEDLINE]Related articles

    14.

    A common disease-associated missense mutation in alpha-sarcoglycan fails to cause muscular dystrophy in mice.

    Kobuke K, Piccolo F, Garringer KW, Moore SA, Sweezer E, Yang B, Campbell KP.

    Hum Mol Genet. 2008 May 1;17(9):1201-13. Epub 2008 Feb 5.PMID: 18252746 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Systemic delivery of AAV8 in utero results in gene expression in diaphragm and limb muscle: treatment implications for muscle disorders.

    Koppanati BM, Li J, Xiao X, Clemens PR.

    Gene Ther. 2009 Sep;16(9):1130-7. Epub 2009 May 28.PMID: 19474806 [PubMed - in process]Related articlesFree article

    16.

    Ultrastructure of diaphragm from dystrophic alpha-sarcoglycan-null mice.

    Jakubiec-Puka A, Biral D, Krawczyk K, Betto R.

    Acta Biochim Pol. 2005;52(2):453-60.PMID: 15990925 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Mannosidase I inhibition rescues the human alpha-sarcoglycan R77C recurrent mutation.

    Bartoli M, Gicquel E, Barrault L, Soheili T, Malissen M, Malissen B, Vincent-Lacaze N, Perez N, Udd B, Danos O, Richard I.

    Hum Mol Genet. 2008 May 1;17(9):1214-21. Epub 2008 Feb 5.PMID: 18252745 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Adeno-associated virus serotype-9 efficiently transduces the retinal outer plexiform layer.

    Lei B, Zhang K, Yue Y, Ghosh A, Duan D.

    Mol Vis. 2009 Jul 17;15:1374-82.PMID: 19626133 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Adeno-associated virus vector genomes persist as episomal chromatin in primate muscle.

    Penaud-Budloo M, Le Guiner C, Nowrouzi A, Toromanoff A, Chérel Y, Chenuaud P, Schmidt M, von Kalle C, Rolling F, Moullier P, Snyder RO.

    J Virol. 2008 Aug;82(16):7875-85. Epub 2008 Jun 4.PMID: 18524821 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye.

    Li W, Kong F, Li X, Dai X, Liu X, Zheng Q, Wu R, Zhou X, Lü F, Chang B, Li Q, Hauswirth WW, Qu J, Pang JJ.

    Mol Vis. 2009;15:267-75. Epub 2009 Feb 6.PMID: 19190735 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk